On Nov. 15, NACDS submitted a letter in response to TDCI’s request for comments on its proposed emergency adoption of rules regarding enforceable pharmacy benefit manager reform regulations.
Prescription drugs make up the majority (98%) of distributors' sales, split among sales of brand-name drugs (55.3%), branded specialty (33.7%), generic drugs (7.8%), generic specialty (.6%) and biosimilar products (.7%).